low cost glp 1 New Medicare GLP-1 Bridge Program Launching July 1, 2026 GLP1 Elevate™ - GLP-1 Booster
Description
About half (49%) of adults ages 65 and older with Medicare say they think it is likely that the Trump administration will lower their prescription drug costs, compared to smaller shares of adults under age 65 with employer-sponsored insurance (34%) or Medicaid (32%)
Banking J.P
SGLT2 inhibitors, a related medication, were initially approved for diabetes, but then subsequently had indications added for heart failure and chronic kidney disease
BMJ 363:k4365
There were no ICP lowering agents or addition of headache preventative drugs started during the study
